DarioHealth Corp. SEC filings DRIO
DarioHealth Corp. has 903 filings in SEC EDGAR's recent list, going back to Nov 1, 2011. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 4, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Dec 22, 2025 | Jan 29, 2026 |
| PRE 14A | Preliminary proxy statement | Dec 11, 2025 | Dec 11, 2025 |
| DEF 14A | Proxy statement | May 30, 2025 | Jul 23, 2025 |
| PRE 14A | Preliminary proxy statement | May 20, 2025 | May 20, 2025 |
| DEF 14A | Proxy statement | Mar 10, 2025 | Apr 28, 2025 |
| PRE 14A | Preliminary proxy statement | Feb 28, 2025 | Feb 28, 2025 |
| DEF 14A | Proxy statement | Oct 24, 2024 | Dec 18, 2024 |
| DEF 14A | Proxy statement | May 1, 2024 | Jun 25, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2024 | Jun 25, 2024 |
| DEF 14A | Proxy statement | Oct 26, 2023 | Dec 11, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 16, 2023 | Dec 11, 2023 |
| DEF 14A | Proxy statement | Oct 14, 2022 | Dec 7, 2022 |
| DEF 14A | Proxy statement | Apr 26, 2021 | Jun 7, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2021 | Jun 7, 2021 |
| DEF 14A | Proxy statement | Sep 2, 2020 | Oct 14, 2020 |
| DEF 14A | Proxy statement | Dec 27, 2019 | Feb 5, 2020 |
| DEF 14A | Proxy statement | Sep 30, 2019 | Nov 6, 2019 |
| PRE 14A | Preliminary proxy statement | Sep 19, 2019 | Nov 6, 2019 |
| DEF 14A | Proxy statement | Oct 22, 2018 | Nov 29, 2018 |
| PRE 14A | Preliminary proxy statement | Oct 12, 2018 | Oct 12, 2018 |
| DEF 14A | Proxy statement | Apr 12, 2018 | May 18, 2018 |
| PRE 14A | Preliminary proxy statement | Mar 26, 2018 | Mar 26, 2018 |
| DEF 14A | Proxy statement | Oct 20, 2017 | Dec 4, 2017 |
| PRE 14A | Preliminary proxy statement | Oct 10, 2017 | Oct 10, 2017 |
| DEF 14A | Proxy statement | Feb 13, 2017 | Mar 9, 2017 |
| PRE 14A | Preliminary proxy statement | Feb 3, 2017 | Feb 3, 2017 |
| DEF 14A | Proxy statement | Oct 19, 2016 | Nov 30, 2016 |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- DRIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1533998
- Former names
- LabStyle Innovations Corp. (until Jul 27, 2016)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.